A Methodology for Evaluating Liquefaction Susceptibility in Shallow Sandy Slopes

This paper illustrates a modeling approach for evaluating the liquefaction susceptibility of shallow sandy slopes. The methodology is based on a theoretical framework for capturing undrained bifurcation in saturated granular media. In order to provide predictive capabilities, the theory is combined with the MIT-S1 constitutive model. The role of a non-homogeneous density profile is investigated, distinguishing among the different forms of undrained response that can be induced by rapid shearing. The first part of the paper describes the general methodology and illustrates the use of a stability index for static liquefaction. In the second part, the practical significance of the approach is discussed by back-analyzing the well-known series of flow failures in an underwater berm at the Nerlerk site. The analyses predict that prior to failure the Nerlerk slopes were not yet beyond the limits of stability for incipient liquefaction. Model simulations, however, also indicate that very small shear perturbations could have activated an undrained instability. These results suggest that static liquefaction was a mechanically plausible failure mechanism and provide the first interpretation of the classical Nerlerk collapse based on the combined use of the theory of material stability and an advanced constitutive model for sands

Fertility, Living Arrangements, Care and Mobility

There are four main interconnecting themes around which the contributions in this book are based. This introductory chapter aims to establish the broad context for the chapters that follow by discussing each of the themes. It does so by setting these themes within the overarching demographic challenge of the twenty-first century – demographic ageing. Each chapter is introduced in the context of the specific theme to which it primarily relates and there is a summary of the data sets used by the contributors to illustrate the wide range of cross-sectional and longitudinal data analysed

Multiwavelength studies of MHD waves in the solar chromosphere: An overview of recent results

The chromosphere is a thin layer of the solar atmosphere that bridges the relatively cool photosphere and the intensely heated transition region and corona. Compressible and incompressible waves propagating through the chromosphere can supply significant amounts of energy to the interface region and corona. In recent years an abundance of high-resolution observations from state-of-the-art facilities have provided new and exciting ways of disentangling the characteristics of oscillatory phenomena propagating through the dynamic chromosphere. Coupled with rapid advancements in magnetohydrodynamic wave theory, we are now in an ideal position to thoroughly investigate the role waves play in supplying energy to sustain chromospheric and coronal heating. Here, we review the recent progress made in characterising, categorising and interpreting oscillations manifesting in the solar chromosphere, with an impetus placed on their intrinsic energetics.Comment: 48 pages, 25 figures, accepted into Space Science Review

An Elasto-plastic Model for Liquefiable Sands Subjected to Torsional Shear Loadings

This paper presents a modeling procedure for simulating the monotonic undrained torsional shear behavior of sands, including stress-strain relationship, and excess pore water pressure generation, while considering the void ratio and stress level dependence of stress-strain-dilatancy behavior of sand. A unique set of soil parameters is required by the model to satisfactorily predict the undrained behavior of loose and dense Toyoura sand over a wide range of initial void ratios and confining pressures, as proven by simulating experimental data produced by the authors and found in the literature

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362